Related Experiment Video
Updated: Jun 15, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Generative models for synthetic data generation: application to pharmacokinetic/pharmacodynamic data
Yulun Jiang1, Alberto García-Durán2, Idris Bachali Losada2
1School of Computer and Communication Science, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland.
Generating synthetic patient data using deep learning models like MLP cGAN can improve data access and availability for clinical research, especially for under-represented patient groups.
Area of Science:
- Clinical Pharmacology
- Biostatistics
- Machine Learning
Background:
- Synthetic patient data generation is crucial for enabling data access and augmenting datasets, particularly for under-represented populations.
- Deep learning generative methods offer advanced solutions for creating realistic synthetic data.
Purpose of the Study:
- To benchmark state-of-the-art deep learning generative methods for synthetic patient data generation.
- To evaluate model performance across diverse clinical datasets and scenarios.
Main Methods:
- Implemented and compared Multi-layer Perceptron Conditioning Generative Adversarial Neural Network (MLP cGAN), Time-series Generative Adversarial Networks (TimeGAN), and Probabilistic Autoregressive (PAR) models.
- Evaluated performance using discriminative and predictive scores, statistical tests (Kolmogorov-Smirnov, Chi-square), and pharmacometrics-related metrics.
Main Results:
- MLP cGAN demonstrated the best overall performance across most evaluated metrics.
- The study confirmed the utility of synthetic data for augmenting and sharing proprietary clinical data.
Conclusions:
- Deep learning generative models, particularly MLP cGAN, are effective for generating high-quality synthetic patient data.
- Synthetic data generation holds significant potential for advancing clinical pharmacology research and data accessibility.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Physiological Models
Mechanistic Models: Overview of Compartment Models
Analysis of Population Pharmacokinetic Data
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

